SCHEMBL5256758

SCHEMBL5256758

O=C1CN(Cc2ccc(F)cc2F)C(=O)[N]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CLPP Q16740 2/20 0.40
ALDH1A1 P00352 4/20 0.38
P2RX7 Q99572 3/20 0.38
TDP1 Q9NUW8 1/20 0.37
IDO1 P14902 2/20 0.37
AGXT P21549 2/20 0.37
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNK3 O14649 1/20 0.36
USP30 Q70CQ3 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4137065 0.85 KDM4E (0.48) KDM4ESMN1; SMN2CLPPALDH1A1P2RX7
SCHEMBL4137157 0.81 ALDH1A1 (0.53) KDM4EALDH1A1P2RX7MEN1CYP1A2
SCHEMBL4955350 0.78 LOXL2 (0.44) KDM4EALDH1A1P2RX7CYP1A2CYP3A4
SCHEMBL4146686 0.75 KDM4E (0.36) KDM4EALDH1A1P2RX7CYP1A2CYP3A4
SCHEMBL4951892 0.74 USP30 (0.35) KDM4ESMN1; SMN2CLPPALDH1A1P2RX7
SCHEMBL4134218 0.73 P2RX7 (0.45) KDM4ESMN1; SMN2ALDH1A1P2RX7TDP1
SCHEMBL8363902 0.72 KDM4E (0.45) KDM4ESMN1; SMN2CLPPALDH1A1P2RX7
SCHEMBL20004077 0.71 KDM4E (0.55) KDM4ESMN1; SMN2CLPPALDH1A1P2RX7
SCHEMBL2732426 0.70 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1P2RX7CYP1A2
SCHEMBL9160595 0.70 KDM4E (0.46) KDM4ESMN1; SMN2ALDH1A1P2RX7TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1423391-B8 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2007-12-12 EP disclosed
EP-1423391-B1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2006-05-17 EP disclosed
EP-1423391-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES Novartis AG (CH) 2004-06-02 EP disclosed
WO-2003020721-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2003-03-13 WO disclosed